{"output": [["Glaukos Corp", "COMP", "Operate_In", "Healthcare Sector", "SECTOR"], ["Glaukos Corp", "COMP", "Produce", "iDose Travoprost", "PRODUCT"], ["iDose Travoprost", "PRODUCT", "Achieve", "Sustained IOP Reduction", "ECON_INDICATOR"], ["iDose Travoprost", "PRODUCT", "Have", "Favorable Safety Profile", "ECON_INDICATOR"], ["Glaukos Corp", "COMP", "Plan", "Phase III U.S. IND Study", "EVENT"], ["Glaukos Corp", "COMP", "Begin", "Process for iDose Travoprost Regulatory Approval", "EVENT"], ["Glaukos Corp", "COMP", "Conduct", "End-of-Phase II Meeting with FDA", "EVENT"]], "published": "2018-01-10T20:10:00.000+02:00"}